Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | SAR442257 |
Trade Name | |
Synonyms | SAR 442257|SAR-442257 |
Drug Descriptions |
SAR442257 is a trispecific T cell engager that targets CD38, CD3 and CD28, which potentially results in enhanced T-cell dependent cytotoxicity of cancer cells (Cancer Res 2020;80(16 Suppl):Abstract nr 5641). |
DrugClasses | CD3 Antibody 97 CD38 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C173645 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SAR442257 | SAR442257 | 0 | 1 |